| For: | Improta-Caria AC, Ferrari F, Gomes JLP, Villalta PB, Soci ÚPR, Stein R, Oliveira EM. Dysregulated microRNAs in type 2 diabetes and breast cancer: Potential associated molecular mechanisms. World J Diabetes 2024; 15(6): 1187-1198 [PMID: 38983808 DOI: 10.4239/wjd.v15.i6.1187] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i6/1187.htm |
| Number | Citing Articles |
| 1 |
Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz. Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04209-5
|
| 2 |
Yuhan Bai, Xiangyi Kong, Jing Wang. Targeting microbiome-driven epigenetic modifications: a new frontier in breast cancer treatment. Clinical Epigenetics 2026; 18(1) doi: 10.1186/s13148-025-02046-0
|
| 3 |
Md. Sadikuj Jaman, Md. Maniruzzaman, Md. Rokibul Hasan Bhuiyan, Md Shajedul Haque, Irfan Ahmad. The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products. International Journal of Breast Cancer 2026; 2026(1) doi: 10.1155/ijbc/2576658
|
| 4 |
I.A. Durrani, P. John, A. Bhatti. Networking Salt Inducible Kinase 1 Regulatory Perturbations on Type 2 Diabetes- Breast Cancer Co-Morbidity Associated Molecular Bridge. The EuroBiotech Journal 2025; 9(1) doi: 10.2478/ebtj-2025-0008
|
| 5 |
Hadeer M. Morsy, Mohamed Y. Zaky, Osama M. Ahmed. MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy. Advances in Biochemistry in Health and Disease 2026; 34 doi: 10.1007/978-3-032-08824-6_20
|